Feb 26, 2019
Vertex, CRISPR Therapeutics treated a patient using CRISPR In the very first, a patient diagnosed with Beta thalassemia was treated using CRISPR gene editing tool by Vertex and CRISPR Therapeutics. CTX001 used to treat the disease, was extracted from hematopoietic stem cells from patients, engineered ex...
Read More...
Feb 25, 2019
Stem Cells therapies and CRISPR gene-editing are not new. Having able to grow the desired cells and manipulate the genome system have proved to be the most important breakthrough so far. We all are aware of the fact that Embryos possess the potential to produce pluripotent cells that researchers experiment on t...
Read More...
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Newsletter/Whitepaper